Switch to:
Also traded in: Germany
» Details

Insider Trades

Latest Guru Trades with SKBI

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Drug Manufacturers » Drug Manufacturers - Major    NAICS: 325412    SIC: 2834
Compare:OTCPK:ECTE, OTCPK:ENZB, OTCPK:INBP, NAS:BSPM, AMEX:CPHI, NAS:ALQA, OTCPK:INNV, NAS:TNXP, OTCPK:SUWN, OTCPK:CHEXF, NAS:NVGN, NAS:IMNP, AMEX:AXN, NAS:PRPH, OTCPK:PXSLY, AMEX:NNVC, OTCPK:BIOYF, NAS:ALIM, NAS:OASM, NAS:ZGNX » details
Traded in other countries:GNJC.Germany,
Skystar Bio-Pharmaceutical Company is a holding company engaged in research, development, manufacturing and distribution of veterinary health care and medical care products in the People's Republic of China.

Skystar Bio-Pharmaceutical Company was incorporated in Nevada on September 24, 1998. The Company is engaged in the research, development, production, marketing, and sales of veterinary healthcare and medical care products. All current operations of the Company are in the People's Republic of China. The Company's operations are carried out by Xi'an Tianxing Bio-Pharmaceutical Co., Limited, a PRC joint stock company that it controls through contractual arrangements originally between Skystar Cayman and Xi'an Tianxing. The Company has four major product lines, namely micro-organism products line; veterinary medicine line; feed additives line; bio-pharmaceutical veterinary vaccine line. Its micro-organism products line includes over 16 products; veterinary medicine line for poultry and livestock includes over 245 products; feed additives line includes over 16 products; and its bio-pharmaceutical veterinary vaccine line includes over 10 products. As of December 31, 2012, the Company had over 4,000 customers in 29 provinces in China, including 2,893 distributors and 1,122 direct customers. Of the 2,893 distributors, 360 are physical stores that have outer signage with its logo and sell products from its four product lines, known as franchise distributors. The Company competes with China Animal Husbandry Industry Co. Ltd. and Qilu Animal Health Production Co., Ltd. in China. In veterinary vaccine products, the Company competes with Xinjiang Tecon Animal Husbandry Bio-technology Co., Ltd. and Inner Mongolia Jinyu Group Stock Company.

Ratios

vs
industry
vs
history

Buy Back

vs
industry
vs
history

Valuation & Return

vs
industry
vs
history

More Statistics

Revenue (TTM) (Mil) $49.05
EPS (TTM) $ 1.35
Beta4.24
Short Percentage of Float1.08%
52-Week Range $0.05 - 0.33
Shares Outstanding (Mil)8.70

Analyst Estimate

Dec14
Revenue (Mil $)
EPS ($) 1.57
EPS without NRI ($) 1.57
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)
» More Articles for SKBI

Headlines

Articles On GuruFocus.com
No related article found.

More From Other Websites
SKYSTAR BIO-PHARMACEUTICAL CO Files SEC form 8-K/A, Changes in Registrant's Certifying Accountant,... Apr 28 2016
SKYSTAR BIO-PHARMACEUTICAL CO Files SEC form 8-K, Changes in Registrant's Certifying Accountant,... Apr 06 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK